SlideShare a Scribd company logo
1 of 42
Thiamine &
Heart Failure
ELIZABETH BAUGH, DIETETIC INTERN
APRIL 27, 2016
About Me
 Dietetic Intern
 Coordinated Program in Dietetics
Purdue University
 Pre and post presentation questionnaires
 Disclosure: no relevant financial or nonfinancial
relationships to disclose.
Overview
 Goal & Objectives
 Introduction to thiamine
 Intake, absorption, storage, RDA’s, toxicity & supplements
 Deficiency
 Types, symptoms, at risk populations
 Medications & Research
 Our Contribution
Goal
 To educate clinical nutrition staff of the benefits of
initiation of thiamin supplementation for heart failure
patients as a routine part of the initial nutrition
assessment
 Currently there are no hospital guidelines for thiamine
supplementation initiation
Objectives
 Understand the benefits of thiamine supplementation in
the hospital setting
 Determine when a patient may be at a higher risk for
thiamine deficiency based off medical history and food
recall
 Recognize mediations that can have an adverse effect
on thiamine levels
 Understand dosing for thiamine deficiency
Introduction
Introduction
Thiamine (thiamin), Vitamin B1
 Water soluble
 Energy, metabolism, growth & cell development
 Coenzyme & non-coenzyme functions
 Synthesis of pentose
 Used in the Krebs cycle for NADH production
 Membrane and nerve conduction
 Synthesized in large intestine, unknown amount
Dietary Intake
 Meats - Pork
 Whole grains, enriched & fortified - cereals, brown rice
 Harmful: heating, pH>8, anti-thiamine factors
 Two forms: free form & phosphorylated form (TPP or TDP)
Image: http://www.namrata.co/wp-content/uploads/2012/08/T1.bmp
Absorption & Storage
 Most effective upper jejunum
 Phosphorylated form
 Hydrolyzed before absorption
 Dietary sources: active transport
 Pharmacological doses: passive diffusion
 Low intake  absorption increases
 No noticeable storage
 40% is stored in muscle
 Half-life is 9.5 to 18.5 days, regular supply
 Adult: 25-30mg, 80% is TPP form
Recommended Dietary Allowance
for Thiamine
Age Male Female Pregnant or lactating
Birth – 6 months 0.2mg 0.2mg
7-12 months 0.3mg 0.3mg
1-3 years 0.5mg 0.5mg
4-8 years 0.6mg 0.6mg
9-13 years 0.9mg 0.9mg
14-18 years 1.2mg 1.0mg 1.4mg
19-50 years 1.2mg 1.1mg 1.4mg
51+ years 1.2mg 1.1mg
Usual Intake
 Deficiency is rare due to many fortified and enriched foods
 U.S. population with intake below EAR – 6%
 Average dietary intake:
 Men – 1.95mg/d Women – 1.39mg/d
 Average dietary & supplements intake:
 Men – 4.89mg/d Women – 4.9mg/d
Toxicity
 No upper levels established
 Lack of toxicity
 Rapid decline in absorption – intake >5mg
 Water soluble
 Intravenous thiamine supplement
 Headaches, convulsions, cardiac arrhythmias, anaphylactic shock
 Administration should be dispersed over 30 minutes
Supplements
 Multivitamin – 1.5mg of thiamine – 100% of DV
 Forms: Thiamine mononitrate & Thiamine hydrochloride
 Stable & water soluble
 World Health Organization (WHO) recommendations for adults
50-100mg/day 10mg/day 3-5mg/day Total time
Mild
deficiency
Oral, 1 week Oral, 6 weeks 7 weeks
Severe
deficiency
Intravenous,
1 week
Intravenous,
1 week
Oral, 6 weeks 8 weeks
Measurement
Offered with IU Health
Whole blood measurement
 Direct measurement of
erythrocyte TPP
 More sensitive than ETKA
 Whole blood testing
 90% of thiamine content of
whole blood is TPP form
 Cost & time
Not offered with IU Health
Plasma blood measurement
 <10% of thiamine is in plasma
 Low specificity & sensitivity
Urinary Thiamine
 excretion, not tissue storage
Erythrocyte transketolase
activity (ETKA) measurement
 actual level of thiamine in tissue
“Serious and potentially irreversible
neurologic damage can occur with
untreated TD, practitioners should
treat the patient without laboratory
confirmation of deficiency and
monitor and evaluate resolution of
signs and symptoms.”
-Frank L, Thamin in Clinical Practice, JPEN (2015)
Deficiencies
Types of Deficiencies
 Early:
 Dry beriberi
 Neurologic
 Wet beriberi
 High-output cardiac
 Gastroenterologic
 Late:
 Wernicke’s encephalopathy
 Neuropsychiatric
 Administration of supplemental
thiamine quickly cures beriberi
http://www.daviddarling.info/encyclopedia/B/beriberi.html
Early Symptoms
 No specific threshold for serum thiamine that will indicate TD
 Weight loss
 Anorexia
 Confusion
 Short term memory loss
 Muscle weakness
 Enlarged heart
Symptoms of Wet Beriberi
 Heart failure with high cardiac output
 Edema in the lower extremities
 Tachycardia or bradycardia
 Lactic acidosis
 Dyspnea
 Heart hypertrophy and dilatation
 Respiratory distress
 Systemic venous hypertension
 Bounding arterial pulsations
Shoshin Beriberi
 Severe form of wet beriberi
 Sudden onset of heart failure
 Cardiovascular collapse
 Metabolic acidosis
 Severe hemodynamic instability
 Can lead to death
Symptoms of Dry Beriberi
 Brisk tendon reflexes
 Peripheral neuropathy
 Muscle weakness
 Pain of upper and lower extremities
 Gait ataxia
 Convulsions
Gastroenterologic Symptoms
 Slow gastric emptying
 Nausea
 Vomiting
 Jejunal dilatation
 Megacolon
 Constipation
Wernicke’s Encephalopathy
 Later stage of thiamine deficiency
 Polyneuropathy
 Ataxia
 Ocular changes
 Confusion
 Short-term memory loss
 Korsakoff psychosis
Populations At Risk For Deficiency
 Alcohol dependence
 Most common cause of thiamine deficiency
 Ethanol reduces gastrointestinal absorption, liver stores, & phosphorylation
 Inadequate intake of essential nutrients
 Older adults
 Possible reasons: low intake, chronic diseases, medications, low absorption
 Risk of deficiency particularly high for elderly who reside in an institution
 Diabetes
 Thiamine plasma levels 76% lower in type 1 diabetics
 Thiamine plasma levels 50-75% lower in type 2 diabetics
Populations At Risk For Deficiency
 HIV/AIDS
 Possible malnutrition due to catabolic state associated with AIDS
 Thiamine deficiency under diagnosed
 Post bariatric surgery
 Risk for severe thiamine deficiency due to malabsorption
 Genetic Beriberi
 Rare, but occurs when body looses ability to absorb thiamine
 Breastfed infants
 If mother is lacking thiamine, infant will as well if milk is only source of nutrition
Medications &
Research
Medications
 No known medical interactions
 Certain medications can alter levels
 Diuretics
 Furosemide – Lasix
 Most frequently prescribed diuretic
 More than heart failure & lack of research
 Chemotherapy
 Fluorouracil – Adrucil
 Used to stop or slow cancer cell growth
Furosemide
Mixed reviews as to if furosemide at various doses is significant
 32 heart failure patients receiving 40mg/d or >80mg/d of furosemide.
 >80mg/d resulted in 98% of patients with severe TD (24/25)
 40mg/d resulted in 57% of patients with severe TD (4/7)
 Thiamine deficiency occurs in a substantial proportion of CHF failure patients being
treated with furosemide
 Furosemide may be inhibit TPP levels at the cellular level by inhibiting uptake
or blocking phosphorylation
Spironolactone & Furosemide
 Spironolactone
 Potassium sparing diuretic
 Spironolactone & furosemide combined
 Patients with heart failure who received both had
significantly higher thiamine levels compared to furosemide
alone
Prevalence of Thiamine Deficiency in
Hospitalized Patients with Congestive
Heart Failure
 100 congestive heart failure patients (CHF) & 50 control subjects
 CHF patents were on furosemide
 Thiamine supplements, other supplements
 Erythrocyte TPP measurements
 Findings:
 TD occurred 33% in CHF patients versus 12% in control
 Multivitamin was found to have a significant association with better
thiamine status in CHF patients
 Did not find a significant relationship between TD and furosemide
dose, urine volume, or urine thiamine excretion
Hanninen S, Darling P, Sole M, Barr A, Keith M. The Prevalence of Thiamin Deficiency in Hospitalized Patients
With Congestive Heart Failure. J Am Coll Cardiol. 2006; 47(2): 354-361.
Prevalence of Thiamine Deficiency
in Hospitalized Patients with Congestive
Heart Failure
 TD was related to urine thiamine loss, non-use of thiamine
containing supplements, and preserved renal function
 Increased urine thiamine excretion was the only significant
positive predictor of thiamine status
 Decreased renal function was significantly associated with
better thiamine status in CHF patients
 Decreased renal function prevents excessive thiamine loss,
preventing TD
Hanninen S, Darling P, Sole M, Barr A, Keith M. The Prevalence of Thiamin Deficiency in Hospitalized Patients
With Congestive Heart Failure. J Am Coll Cardiol. 2006; 47(2): 354-361.
Left Ventricle Ejection Fraction &
Thiamine
 9 patients, diuretics – unknown what type
 Congestive heart failure & left ventricle ejection fraction <40%
 Thiamine (300mg) or placebo
 28 days, 6 week washout period, cross over to second 28 day period
 Left ventricle ejection fraction baseline for both groups was 29.5%
 Result: Thiamine treatment resulted in an increase in LVEF of 3.9%
 Thiamine supplementation has positive effects on cardiac function for
patients taking diuretic drugs for symptomatic CHF
Schoenenberger A, Schoenenberger-Berzins R, Maur C Suter P, Vergopoulos A, Erne P.
Thiamine supplementation in symptomatic chronic heart failure: a randomized, double-blind,
placebo-controlled, cross-over pilot Study. Clin Res Cardiol. 2012; 101:159–164.
Our Contributation
Our Contributation
 Be an advocate for early thiamine supplementation
 Work towards early initiation of thiamine supplementation when patient is
placed on diuretics or at risk for deficiency
 IU Methodist options:
 Oral nutrition supplements
 Enteral nutrition
 Parenteral nutrition
 Multivitamins
 Thiamine supplements
Brief Review
 RDA
 Men: 1.2mg Women: 1.1mg Lactating or pregnant: 1.4mg
 World Health Organization (WHO) recommendations for adults
50-100mg/day 10mg/day 3-5mg/day Total time
Mild
deficiency
Oral, 1 week Oral, 6 weeks 7 weeks
Severe
deficiency
Intravenous*,
1 week
Intravenous*,
1 week
Oral, 6 weeks 8 weeks
*Intravenous injection should be dispersed over 30+ minutes
Oral Nutrition Supplements
Product Mg/serving Servings per day to meet RDA
Ensure Clear 0.3 4
Ensure Complete 0.38 3.15
Glucerna 0.38 3.15
Nepro with Carbsteady 0.58 3
 Consider: cumulative nutrition dose
Nutrition Support
Enteral Nutrition
Parenteral Nutrition
 6mg thiamine per 10mL per day
Mg/L Product
1.7 Vivonex RTF
2.1 Vital High Protein
2.3 Jevity 1.2 &1.5. Osmolite 1.2, Promote
2.4 Nepro with Carbsteady
2.5 Vital AF 1.2
2.6 TwoCal
3 Impact Peptide 1.5, Osmolite 1.5, Vital 1.5
Multivitamins & Thiamine Supplements
 Multivitamins – contain thiamine hydrochloride
 Thiamine Supplements
 Injection – 100mg/2mL
 Oral tablets – 50mg & 100mg
Adult multivit w/ minerals 3mg per tablet
Pediatric multivitamin w/ minerals (Flintstones) 3mg per 2 tablets
Prenatal Vitamin 1.8mg per tablet
HD multivit, Adult or ocular multivit, Flintstones 1.5ng per tablet
CF & Bariatric multivitamin 1.5mg per 2 tablets
Liquid adult multivitamin 1.5mg per 15mL
Pediatric multivitamins – with or without iron 0.5mg per 1mL
Objectives Review
 Understand the benefits of thiamine supplementation in
the hospital setting
 Determine when a patient may be at a higher risk for
thiamine deficiency based off medical history and food
recall
 Recognize mediations that can have an adverse effect
on thiamine levels
 Understand dosing for thiamine deficiency
References
 Thiamine. Medline Plus. https://www.nlm.nih.gov/medlineplus/druginfo/natural/965.html.
Updated March 17, 2015. Accessed April 20, 2016.
 Beriberi. Medline Plus. https://www.nlm.nih.gov/medlineplus/ency/article/000339.htm. Updated
August 17, 2014. Accessed April 20, 2016.
 Thiamin. National Institutes of Health. https://ods.od.nih.gov/factsheets/Thiamin-
HealthProfessional/. Updated February 11, 2016. Accessed April 20, 2016.
 Hanninen S, Darling P, Sole M, Barr A, Keith M. The Prevalence of Thiamin Deficiency in
Hospitalized Patients With Congestive Heart Failure. J Am Coll Cardiol. 2006; 47(2): 354-361.
 Schoenenberger A, Schoenenberger-Berzins R, Maur C Suter P, Vergopoulos A, Erne P.
Thiamine supplementation in symptomatic chronic heart failure: a randomized, double-blind,
placebo-controlled, cross-over pilot Study. Clin Res Cardiol. 2012; 101:159–164.
 Frank L. Thiamin in Clinical Practice. JPEN. 2015; 39(5): 503-520.
 Sica D. Loop Diuretic Therapy, Thiamine Balance, and Heart Failure. Congest Heart Fail. 2007;
13(4): 244-247.
 Katta N, Balla S, Alpert M. Does Long-Term Furosemide Therapy Cause Thiamine Deficiency in
Patients with Heart Failure? A Focused Review. AM J MED. 2016.
 Rieck J, Halkin H, Almog S, et al. Urinary loss of thiamine is increased by low doses of
furosemide in healthy volunteers. J Lab Clin Med. 1999; 134: 238-243
Thank You!
Questions?

More Related Content

What's hot

2013-AMIA-Slides
2013-AMIA-Slides2013-AMIA-Slides
2013-AMIA-Slides
John Schrom
 
Case on type II diabetes mellitus with peripheral neuropathy with hypertension
Case on type II diabetes mellitus with peripheral neuropathy with hypertensionCase on type II diabetes mellitus with peripheral neuropathy with hypertension
Case on type II diabetes mellitus with peripheral neuropathy with hypertension
Vineetha Menon
 
Atorwin rtd 2014 dr sukartono
Atorwin   rtd 2014 dr sukartonoAtorwin   rtd 2014 dr sukartono
Atorwin rtd 2014 dr sukartono
Familiantoro Maun
 

What's hot (18)

2013-AMIA-Slides
2013-AMIA-Slides2013-AMIA-Slides
2013-AMIA-Slides
 
Treatment of hypertension
Treatment of hypertensionTreatment of hypertension
Treatment of hypertension
 
Rosuvastatin
RosuvastatinRosuvastatin
Rosuvastatin
 
Complementary and alternative therapies for Coronary Heart Disease (CHD)
Complementary and alternative  therapies for Coronary Heart Disease (CHD)Complementary and alternative  therapies for Coronary Heart Disease (CHD)
Complementary and alternative therapies for Coronary Heart Disease (CHD)
 
Current status & recent advances in dyslipidemia management
Current status & recent advances in dyslipidemia managementCurrent status & recent advances in dyslipidemia management
Current status & recent advances in dyslipidemia management
 
Case on type II diabetes mellitus with peripheral neuropathy with hypertension
Case on type II diabetes mellitus with peripheral neuropathy with hypertensionCase on type II diabetes mellitus with peripheral neuropathy with hypertension
Case on type II diabetes mellitus with peripheral neuropathy with hypertension
 
Guidelines for treatment of hypertension
Guidelines for treatment of  hypertensionGuidelines for treatment of  hypertension
Guidelines for treatment of hypertension
 
Antihypertensive drugs
Antihypertensive drugsAntihypertensive drugs
Antihypertensive drugs
 
Dyslipidemia and Management of Dyslipidemia | Muhammad-Nizam-Uddin
Dyslipidemia and Management of Dyslipidemia | Muhammad-Nizam-UddinDyslipidemia and Management of Dyslipidemia | Muhammad-Nizam-Uddin
Dyslipidemia and Management of Dyslipidemia | Muhammad-Nizam-Uddin
 
Hypertension Cheat Sheet
Hypertension Cheat SheetHypertension Cheat Sheet
Hypertension Cheat Sheet
 
Atorwin rtd 2014 dr sukartono
Atorwin   rtd 2014 dr sukartonoAtorwin   rtd 2014 dr sukartono
Atorwin rtd 2014 dr sukartono
 
Indian lipid guideline 2016 dibu final
Indian lipid guideline 2016 dibu final Indian lipid guideline 2016 dibu final
Indian lipid guideline 2016 dibu final
 
Hypertension Management
Hypertension ManagementHypertension Management
Hypertension Management
 
Dyslipidemia management an evidence based approach
Dyslipidemia management an evidence based approachDyslipidemia management an evidence based approach
Dyslipidemia management an evidence based approach
 
case study on HYPOTHYROIDISM
case study on HYPOTHYROIDISMcase study on HYPOTHYROIDISM
case study on HYPOTHYROIDISM
 
Case study-10-depression
Case study-10-depressionCase study-10-depression
Case study-10-depression
 
Mellss yr4 primary care hypertension
Mellss yr4 primary care hypertensionMellss yr4 primary care hypertension
Mellss yr4 primary care hypertension
 
Diabetic Dyslipidemia- Dr Shahjada Selim
Diabetic Dyslipidemia- Dr Shahjada SelimDiabetic Dyslipidemia- Dr Shahjada Selim
Diabetic Dyslipidemia- Dr Shahjada Selim
 

Viewers also liked

спорту – крым! керчь.
спорту – крым! керчь.спорту – крым! керчь.
спорту – крым! керчь.
Kupola
 
E-Brochure Noida World One (1)
E-Brochure Noida World One (1)E-Brochure Noida World One (1)
E-Brochure Noida World One (1)
saurabh manchanda
 
Спортивные сборы в Красной Поляне
Спортивные сборы в Красной ПолянеСпортивные сборы в Красной Поляне
Спортивные сборы в Красной Поляне
Kupola
 
helpaholic - Get Hired Presentation
helpaholic - Get Hired Presentationhelpaholic - Get Hired Presentation
helpaholic - Get Hired Presentation
Jessica Karnes
 
Linkedin personal resume 20150128
Linkedin personal resume 20150128Linkedin personal resume 20150128
Linkedin personal resume 20150128
Edward Chao
 

Viewers also liked (19)

STC Comercial
STC ComercialSTC Comercial
STC Comercial
 
What you need to know about fasfa
What you need to know about fasfaWhat you need to know about fasfa
What you need to know about fasfa
 
Jonathan Mulosa ET'Al
Jonathan Mulosa ET'AlJonathan Mulosa ET'Al
Jonathan Mulosa ET'Al
 
resume
resumeresume
resume
 
Inspiration and moodboard
Inspiration and moodboardInspiration and moodboard
Inspiration and moodboard
 
Set Apart For Greatness
Set Apart For GreatnessSet Apart For Greatness
Set Apart For Greatness
 
Edward via College of Osteopathic Medicine
Edward via College of Osteopathic MedicineEdward via College of Osteopathic Medicine
Edward via College of Osteopathic Medicine
 
спорту – крым! керчь.
спорту – крым! керчь.спорту – крым! керчь.
спорту – крым! керчь.
 
Cifosis para defender
Cifosis para defenderCifosis para defender
Cifosis para defender
 
Production processes
Production processesProduction processes
Production processes
 
Yader
YaderYader
Yader
 
CV - 16032016
CV - 16032016CV - 16032016
CV - 16032016
 
E-Brochure Noida World One (1)
E-Brochure Noida World One (1)E-Brochure Noida World One (1)
E-Brochure Noida World One (1)
 
Спортивные сборы в Красной Поляне
Спортивные сборы в Красной ПолянеСпортивные сборы в Красной Поляне
Спортивные сборы в Красной Поляне
 
Inspiration and moodboard
Inspiration and moodboardInspiration and moodboard
Inspiration and moodboard
 
Diversity discovery class 2013 (summary ppt)
Diversity discovery class 2013 (summary ppt)Diversity discovery class 2013 (summary ppt)
Diversity discovery class 2013 (summary ppt)
 
helpaholic - Get Hired Presentation
helpaholic - Get Hired Presentationhelpaholic - Get Hired Presentation
helpaholic - Get Hired Presentation
 
Спартакиада - ГТО для компаниии
Спартакиада - ГТО для компаниииСпартакиада - ГТО для компаниии
Спартакиада - ГТО для компаниии
 
Linkedin personal resume 20150128
Linkedin personal resume 20150128Linkedin personal resume 20150128
Linkedin personal resume 20150128
 

Similar to Thamine presentation suggestions (1)

Management of hyperemesis gravidarum guidelines - copy
Management of hyperemesis gravidarum  guidelines - copy Management of hyperemesis gravidarum  guidelines - copy
Management of hyperemesis gravidarum guidelines - copy
Lifecare Centre
 
Endocrinology Lect2,3 2003
Endocrinology Lect2,3  2003Endocrinology Lect2,3  2003
Endocrinology Lect2,3 2003
guest233fe0
 
Endocrinology Lect2,3 2003
Endocrinology Lect2,3  2003Endocrinology Lect2,3  2003
Endocrinology Lect2,3 2003
Miami Dade
 
Assessment_and_Management_of_Patients_with_Endocrine_Disorders.ppt
Assessment_and_Management_of_Patients_with_Endocrine_Disorders.pptAssessment_and_Management_of_Patients_with_Endocrine_Disorders.ppt
Assessment_and_Management_of_Patients_with_Endocrine_Disorders.ppt
Ahmed569160
 
Nutrition support in cardiovascular disease
Nutrition support in cardiovascular diseaseNutrition support in cardiovascular disease
Nutrition support in cardiovascular disease
Dr.Abdul Shaikh
 

Similar to Thamine presentation suggestions (1) (20)

Antihypertensive drugs
Antihypertensive drugsAntihypertensive drugs
Antihypertensive drugs
 
Elderlypreg drugs pracs ug
Elderlypreg drugs pracs ugElderlypreg drugs pracs ug
Elderlypreg drugs pracs ug
 
Eating disorders unit 10
Eating disorders unit 10Eating disorders unit 10
Eating disorders unit 10
 
HYPERPARATHROIDISM and hypopera PPT.pptx
HYPERPARATHROIDISM and hypopera PPT.pptxHYPERPARATHROIDISM and hypopera PPT.pptx
HYPERPARATHROIDISM and hypopera PPT.pptx
 
Management of hyperemesis gravidarum guidelines - copy
Management of hyperemesis gravidarum  guidelines - copy Management of hyperemesis gravidarum  guidelines - copy
Management of hyperemesis gravidarum guidelines - copy
 
Endocrinology Lect2,3 2003
Endocrinology Lect2,3  2003Endocrinology Lect2,3  2003
Endocrinology Lect2,3 2003
 
Endocrinology Lect2,3 2003
Endocrinology Lect2,3  2003Endocrinology Lect2,3  2003
Endocrinology Lect2,3 2003
 
Lvn pharm test5
Lvn pharm test5Lvn pharm test5
Lvn pharm test5
 
synovial chondrosarcoma Case directory
synovial chondrosarcoma Case directorysynovial chondrosarcoma Case directory
synovial chondrosarcoma Case directory
 
Assessment_and_Management_of_Patients_with_Endocrine_Disorders.ppt
Assessment_and_Management_of_Patients_with_Endocrine_Disorders.pptAssessment_and_Management_of_Patients_with_Endocrine_Disorders.ppt
Assessment_and_Management_of_Patients_with_Endocrine_Disorders.ppt
 
Pulmonary hypertension
Pulmonary hypertensionPulmonary hypertension
Pulmonary hypertension
 
Peripartum cardiomyopathy
Peripartum cardiomyopathyPeripartum cardiomyopathy
Peripartum cardiomyopathy
 
Nutrition support in cardiovascular disease
Nutrition support in cardiovascular diseaseNutrition support in cardiovascular disease
Nutrition support in cardiovascular disease
 
Thyroid
ThyroidThyroid
Thyroid
 
HYPERTHYROIDISM
HYPERTHYROIDISMHYPERTHYROIDISM
HYPERTHYROIDISM
 
Hypertension
HypertensionHypertension
Hypertension
 
Medication in Geriatrics.pptx
Medication in Geriatrics.pptxMedication in Geriatrics.pptx
Medication in Geriatrics.pptx
 
Essential Hypertension
Essential Hypertension Essential Hypertension
Essential Hypertension
 
Case presentation on MYOCARDIAL INFARCTION
Case presentation on MYOCARDIAL INFARCTIONCase presentation on MYOCARDIAL INFARCTION
Case presentation on MYOCARDIAL INFARCTION
 
Ysg final ppt 27
Ysg final ppt 27Ysg final ppt 27
Ysg final ppt 27
 

Thamine presentation suggestions (1)

  • 1. Thiamine & Heart Failure ELIZABETH BAUGH, DIETETIC INTERN APRIL 27, 2016
  • 2. About Me  Dietetic Intern  Coordinated Program in Dietetics Purdue University  Pre and post presentation questionnaires  Disclosure: no relevant financial or nonfinancial relationships to disclose.
  • 3. Overview  Goal & Objectives  Introduction to thiamine  Intake, absorption, storage, RDA’s, toxicity & supplements  Deficiency  Types, symptoms, at risk populations  Medications & Research  Our Contribution
  • 4. Goal  To educate clinical nutrition staff of the benefits of initiation of thiamin supplementation for heart failure patients as a routine part of the initial nutrition assessment  Currently there are no hospital guidelines for thiamine supplementation initiation
  • 5. Objectives  Understand the benefits of thiamine supplementation in the hospital setting  Determine when a patient may be at a higher risk for thiamine deficiency based off medical history and food recall  Recognize mediations that can have an adverse effect on thiamine levels  Understand dosing for thiamine deficiency
  • 7. Introduction Thiamine (thiamin), Vitamin B1  Water soluble  Energy, metabolism, growth & cell development  Coenzyme & non-coenzyme functions  Synthesis of pentose  Used in the Krebs cycle for NADH production  Membrane and nerve conduction  Synthesized in large intestine, unknown amount
  • 8. Dietary Intake  Meats - Pork  Whole grains, enriched & fortified - cereals, brown rice  Harmful: heating, pH>8, anti-thiamine factors  Two forms: free form & phosphorylated form (TPP or TDP) Image: http://www.namrata.co/wp-content/uploads/2012/08/T1.bmp
  • 9. Absorption & Storage  Most effective upper jejunum  Phosphorylated form  Hydrolyzed before absorption  Dietary sources: active transport  Pharmacological doses: passive diffusion  Low intake  absorption increases  No noticeable storage  40% is stored in muscle  Half-life is 9.5 to 18.5 days, regular supply  Adult: 25-30mg, 80% is TPP form
  • 10. Recommended Dietary Allowance for Thiamine Age Male Female Pregnant or lactating Birth – 6 months 0.2mg 0.2mg 7-12 months 0.3mg 0.3mg 1-3 years 0.5mg 0.5mg 4-8 years 0.6mg 0.6mg 9-13 years 0.9mg 0.9mg 14-18 years 1.2mg 1.0mg 1.4mg 19-50 years 1.2mg 1.1mg 1.4mg 51+ years 1.2mg 1.1mg
  • 11. Usual Intake  Deficiency is rare due to many fortified and enriched foods  U.S. population with intake below EAR – 6%  Average dietary intake:  Men – 1.95mg/d Women – 1.39mg/d  Average dietary & supplements intake:  Men – 4.89mg/d Women – 4.9mg/d
  • 12. Toxicity  No upper levels established  Lack of toxicity  Rapid decline in absorption – intake >5mg  Water soluble  Intravenous thiamine supplement  Headaches, convulsions, cardiac arrhythmias, anaphylactic shock  Administration should be dispersed over 30 minutes
  • 13. Supplements  Multivitamin – 1.5mg of thiamine – 100% of DV  Forms: Thiamine mononitrate & Thiamine hydrochloride  Stable & water soluble  World Health Organization (WHO) recommendations for adults 50-100mg/day 10mg/day 3-5mg/day Total time Mild deficiency Oral, 1 week Oral, 6 weeks 7 weeks Severe deficiency Intravenous, 1 week Intravenous, 1 week Oral, 6 weeks 8 weeks
  • 14. Measurement Offered with IU Health Whole blood measurement  Direct measurement of erythrocyte TPP  More sensitive than ETKA  Whole blood testing  90% of thiamine content of whole blood is TPP form  Cost & time Not offered with IU Health Plasma blood measurement  <10% of thiamine is in plasma  Low specificity & sensitivity Urinary Thiamine  excretion, not tissue storage Erythrocyte transketolase activity (ETKA) measurement  actual level of thiamine in tissue
  • 15. “Serious and potentially irreversible neurologic damage can occur with untreated TD, practitioners should treat the patient without laboratory confirmation of deficiency and monitor and evaluate resolution of signs and symptoms.” -Frank L, Thamin in Clinical Practice, JPEN (2015)
  • 17. Types of Deficiencies  Early:  Dry beriberi  Neurologic  Wet beriberi  High-output cardiac  Gastroenterologic  Late:  Wernicke’s encephalopathy  Neuropsychiatric  Administration of supplemental thiamine quickly cures beriberi http://www.daviddarling.info/encyclopedia/B/beriberi.html
  • 18. Early Symptoms  No specific threshold for serum thiamine that will indicate TD  Weight loss  Anorexia  Confusion  Short term memory loss  Muscle weakness  Enlarged heart
  • 19. Symptoms of Wet Beriberi  Heart failure with high cardiac output  Edema in the lower extremities  Tachycardia or bradycardia  Lactic acidosis  Dyspnea  Heart hypertrophy and dilatation  Respiratory distress  Systemic venous hypertension  Bounding arterial pulsations
  • 20. Shoshin Beriberi  Severe form of wet beriberi  Sudden onset of heart failure  Cardiovascular collapse  Metabolic acidosis  Severe hemodynamic instability  Can lead to death
  • 21. Symptoms of Dry Beriberi  Brisk tendon reflexes  Peripheral neuropathy  Muscle weakness  Pain of upper and lower extremities  Gait ataxia  Convulsions
  • 22. Gastroenterologic Symptoms  Slow gastric emptying  Nausea  Vomiting  Jejunal dilatation  Megacolon  Constipation
  • 23. Wernicke’s Encephalopathy  Later stage of thiamine deficiency  Polyneuropathy  Ataxia  Ocular changes  Confusion  Short-term memory loss  Korsakoff psychosis
  • 24. Populations At Risk For Deficiency  Alcohol dependence  Most common cause of thiamine deficiency  Ethanol reduces gastrointestinal absorption, liver stores, & phosphorylation  Inadequate intake of essential nutrients  Older adults  Possible reasons: low intake, chronic diseases, medications, low absorption  Risk of deficiency particularly high for elderly who reside in an institution  Diabetes  Thiamine plasma levels 76% lower in type 1 diabetics  Thiamine plasma levels 50-75% lower in type 2 diabetics
  • 25. Populations At Risk For Deficiency  HIV/AIDS  Possible malnutrition due to catabolic state associated with AIDS  Thiamine deficiency under diagnosed  Post bariatric surgery  Risk for severe thiamine deficiency due to malabsorption  Genetic Beriberi  Rare, but occurs when body looses ability to absorb thiamine  Breastfed infants  If mother is lacking thiamine, infant will as well if milk is only source of nutrition
  • 27. Medications  No known medical interactions  Certain medications can alter levels  Diuretics  Furosemide – Lasix  Most frequently prescribed diuretic  More than heart failure & lack of research  Chemotherapy  Fluorouracil – Adrucil  Used to stop or slow cancer cell growth
  • 28. Furosemide Mixed reviews as to if furosemide at various doses is significant  32 heart failure patients receiving 40mg/d or >80mg/d of furosemide.  >80mg/d resulted in 98% of patients with severe TD (24/25)  40mg/d resulted in 57% of patients with severe TD (4/7)  Thiamine deficiency occurs in a substantial proportion of CHF failure patients being treated with furosemide  Furosemide may be inhibit TPP levels at the cellular level by inhibiting uptake or blocking phosphorylation
  • 29. Spironolactone & Furosemide  Spironolactone  Potassium sparing diuretic  Spironolactone & furosemide combined  Patients with heart failure who received both had significantly higher thiamine levels compared to furosemide alone
  • 30. Prevalence of Thiamine Deficiency in Hospitalized Patients with Congestive Heart Failure  100 congestive heart failure patients (CHF) & 50 control subjects  CHF patents were on furosemide  Thiamine supplements, other supplements  Erythrocyte TPP measurements  Findings:  TD occurred 33% in CHF patients versus 12% in control  Multivitamin was found to have a significant association with better thiamine status in CHF patients  Did not find a significant relationship between TD and furosemide dose, urine volume, or urine thiamine excretion Hanninen S, Darling P, Sole M, Barr A, Keith M. The Prevalence of Thiamin Deficiency in Hospitalized Patients With Congestive Heart Failure. J Am Coll Cardiol. 2006; 47(2): 354-361.
  • 31. Prevalence of Thiamine Deficiency in Hospitalized Patients with Congestive Heart Failure  TD was related to urine thiamine loss, non-use of thiamine containing supplements, and preserved renal function  Increased urine thiamine excretion was the only significant positive predictor of thiamine status  Decreased renal function was significantly associated with better thiamine status in CHF patients  Decreased renal function prevents excessive thiamine loss, preventing TD Hanninen S, Darling P, Sole M, Barr A, Keith M. The Prevalence of Thiamin Deficiency in Hospitalized Patients With Congestive Heart Failure. J Am Coll Cardiol. 2006; 47(2): 354-361.
  • 32. Left Ventricle Ejection Fraction & Thiamine  9 patients, diuretics – unknown what type  Congestive heart failure & left ventricle ejection fraction <40%  Thiamine (300mg) or placebo  28 days, 6 week washout period, cross over to second 28 day period  Left ventricle ejection fraction baseline for both groups was 29.5%  Result: Thiamine treatment resulted in an increase in LVEF of 3.9%  Thiamine supplementation has positive effects on cardiac function for patients taking diuretic drugs for symptomatic CHF Schoenenberger A, Schoenenberger-Berzins R, Maur C Suter P, Vergopoulos A, Erne P. Thiamine supplementation in symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled, cross-over pilot Study. Clin Res Cardiol. 2012; 101:159–164.
  • 34. Our Contributation  Be an advocate for early thiamine supplementation  Work towards early initiation of thiamine supplementation when patient is placed on diuretics or at risk for deficiency  IU Methodist options:  Oral nutrition supplements  Enteral nutrition  Parenteral nutrition  Multivitamins  Thiamine supplements
  • 35. Brief Review  RDA  Men: 1.2mg Women: 1.1mg Lactating or pregnant: 1.4mg  World Health Organization (WHO) recommendations for adults 50-100mg/day 10mg/day 3-5mg/day Total time Mild deficiency Oral, 1 week Oral, 6 weeks 7 weeks Severe deficiency Intravenous*, 1 week Intravenous*, 1 week Oral, 6 weeks 8 weeks *Intravenous injection should be dispersed over 30+ minutes
  • 36. Oral Nutrition Supplements Product Mg/serving Servings per day to meet RDA Ensure Clear 0.3 4 Ensure Complete 0.38 3.15 Glucerna 0.38 3.15 Nepro with Carbsteady 0.58 3  Consider: cumulative nutrition dose
  • 37. Nutrition Support Enteral Nutrition Parenteral Nutrition  6mg thiamine per 10mL per day Mg/L Product 1.7 Vivonex RTF 2.1 Vital High Protein 2.3 Jevity 1.2 &1.5. Osmolite 1.2, Promote 2.4 Nepro with Carbsteady 2.5 Vital AF 1.2 2.6 TwoCal 3 Impact Peptide 1.5, Osmolite 1.5, Vital 1.5
  • 38. Multivitamins & Thiamine Supplements  Multivitamins – contain thiamine hydrochloride  Thiamine Supplements  Injection – 100mg/2mL  Oral tablets – 50mg & 100mg Adult multivit w/ minerals 3mg per tablet Pediatric multivitamin w/ minerals (Flintstones) 3mg per 2 tablets Prenatal Vitamin 1.8mg per tablet HD multivit, Adult or ocular multivit, Flintstones 1.5ng per tablet CF & Bariatric multivitamin 1.5mg per 2 tablets Liquid adult multivitamin 1.5mg per 15mL Pediatric multivitamins – with or without iron 0.5mg per 1mL
  • 39. Objectives Review  Understand the benefits of thiamine supplementation in the hospital setting  Determine when a patient may be at a higher risk for thiamine deficiency based off medical history and food recall  Recognize mediations that can have an adverse effect on thiamine levels  Understand dosing for thiamine deficiency
  • 40. References  Thiamine. Medline Plus. https://www.nlm.nih.gov/medlineplus/druginfo/natural/965.html. Updated March 17, 2015. Accessed April 20, 2016.  Beriberi. Medline Plus. https://www.nlm.nih.gov/medlineplus/ency/article/000339.htm. Updated August 17, 2014. Accessed April 20, 2016.  Thiamin. National Institutes of Health. https://ods.od.nih.gov/factsheets/Thiamin- HealthProfessional/. Updated February 11, 2016. Accessed April 20, 2016.  Hanninen S, Darling P, Sole M, Barr A, Keith M. The Prevalence of Thiamin Deficiency in Hospitalized Patients With Congestive Heart Failure. J Am Coll Cardiol. 2006; 47(2): 354-361.  Schoenenberger A, Schoenenberger-Berzins R, Maur C Suter P, Vergopoulos A, Erne P. Thiamine supplementation in symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled, cross-over pilot Study. Clin Res Cardiol. 2012; 101:159–164.  Frank L. Thiamin in Clinical Practice. JPEN. 2015; 39(5): 503-520.  Sica D. Loop Diuretic Therapy, Thiamine Balance, and Heart Failure. Congest Heart Fail. 2007; 13(4): 244-247.  Katta N, Balla S, Alpert M. Does Long-Term Furosemide Therapy Cause Thiamine Deficiency in Patients with Heart Failure? A Focused Review. AM J MED. 2016.  Rieck J, Halkin H, Almog S, et al. Urinary loss of thiamine is increased by low doses of furosemide in healthy volunteers. J Lab Clin Med. 1999; 134: 238-243

Editor's Notes

  1. Heating foods can decrease thiamin content and since it is water soluble, a significant amount of the vitamin can be lost when the cooking water is discarded. Anti-thiamine factors: raw fish – thiaminases. Polyhydrophenols - tannic & caffeic acids found in coffee, tea, betel nuts, blueberries, black currents, Brussels spouts, & red cabbage Plant sources contain free thiamine Animal sources >95% is phosphorylated form
  2. Lesser amount: duodenum & ileum
  3. Mild – all oral doses Severe – intravenous weeks 1 and 2, oral weeks 3-9
  4. The plasma or serum thiamine level does not accurately represent body thiamine status because it contains only a fraction of the total body thiamine. Indirect measurement Measure erythrocyte transketolase activity (ETKA) Uses TPP Influenced by other factors Healthy individual: 0-15% Marginal deficiency: 15-25% Deficiency: >25% Measuring ETKA – actual level of thiamine tissue levels. FYI- We do not have this lab available to check in Cerner. Urinary thiamine Measure of thiamine excretion but not tissue storage Adequate intake: >100mcg/d Insufficient intake: <100mcg/d Extremely low intake:<40mcg/d Urine thiamine levels provide information about thiamine intake, but not about the tissue stores Plasma measurement <10% of blood thiamine is in the plasma Suffers from low specificity & sensitivity Affected by disease states Sepsis, CABG, trauma Renal replacement therapy Decreases Hepatic injury Increases
  5. Supplemental thiamine can cure beriberi, but depending on the severity of the damage, it may be past the point of no return
  6. Tachycardia – Rapid heart beat Bradycardia – slow heart beat Example of Supplemental thiamine can cure beriberi, but depending on the severity of the damage, it may be past the point of no return Can cause heart failure, but it will reach a point that the damage has been done.
  7. Ataxia - the loss of full control of bodily movements. Without treatment, 20% of people with wernickes die The rest develop korsakoff’s psychosis
  8. See sticky note
  9. Autopsies of 380 people with AIDS (not HIV), 10% had wernicke’s encephalopathy.
  10. blocking the absorption of sodium, chloride, and water from the filtered fluid in the kidney tubules, causing a profound increase in the output of urine Due to the lack of research on thiamine deficiency associated with bumetanide and torsemide, little is known about their relationship. Most frequently prescribed diuretic Furosdemine intake must be marginal
  11. Loop: blocking the absorption of sodium, chloride, and water from the filtered fluid in the kidney tubules, causing a profound increase in the output of urine Potassium sparing diuretic - interfering with the sodium-potassium exchange in the distal convoluted tubule in the kidneys
  12. Excluded those who were being treated with thiamine supplements (200mg/d) for alcohol abuse Control group were subjects that were age(+/- 5 years) and of the same gender and were excluded if they were taking any thiamine supplements or had disease that may affect thiamine status. Some patients were also on spironlactone and metalazone
  13. Suggesting that increased urine thiamin excretion independently predicts better thiamin status Since studies in healthy adults suggest that urine thiamin excretion is positively correlated with dietary thiamin intake and blood thiamin concentrations, our urinary thiamin excretion may simply reflect the amount of thiamin consumed in the diet and supplements
  14. No vitamin supplements, renal failure, or fertile women
  15. Thiamine availability at Methodist
  16. Consider: cumulative nutrition dose
  17. Need to edit – more actual